Cargando…

Screening Technologies for Target Identification in Pancreatic Cancer

Pancreatic cancer exhibits an extraordinarily high level of resistance to almost any kind of systemic therapy evaluated in clinical trials so far. Therefore, the identification of novel therapeutic targets is urgently required. High-throughput screens have emerged as an important tool to identify pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Michl, Patrick, Ripka, Stefanie, Gress, Thomas, Buchholz, Malte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756350/
https://www.ncbi.nlm.nih.gov/pubmed/24212607
http://dx.doi.org/10.3390/cancers3010079